To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder

NCT04917315 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: JLP-2002 A mg
DRUG: Placebo

Sponsor

Jeil Pharmaceutical Co., Ltd.